What Researchers Did
Researchers conducted a systematic review of the literature to evaluate the screening, diagnosis, prophylaxis, and treatment strategies for intrauterine growth restriction using PubMed and Cochrane databases.
What They Found
They found that screening involves identifying risk factors and measuring symphysis-fundus height, with diagnosis verified by ultrasonography, potentially improved by customized growth curves and 3-dimensional ultrasonography. Prophylaxis with acetylsalicylic acid, started in the first or second trimester, or combined with heparin before conception, may reduce IUGR incidence in high-risk groups. Antenatal corticosteroids reduce associated perinatal morbidity and mortality, while bed rest showed no demonstrated beneficial effects.
What This Means for Canadian Patients
Canadian patients at high risk for intrauterine growth restriction may benefit from early screening, including risk factor identification and symphysis-fundus height measurements, followed by accurate ultrasonographic diagnosis. Prophylactic measures like acetylsalicylic acid in the first or second trimester and antenatal corticosteroids for confirmed cases could improve outcomes, while ineffective interventions like bed rest should be avoided.
Canadian Relevance
This systematic review does not have a direct Canadian connection as it was not conducted by Canadian researchers, nor does it specifically focus on the Canadian healthcare context.
Study Limitations
A potential limitation of this systematic review is its reliance on specific databases (PubMed and Cochrane) and keywords, which may not have captured all relevant literature on intrauterine growth restriction.